胆调节剂在精神分裂症患者中的有效性和安全性:随机对照试验的元分析
Amiya Shaju1, Archana Mishra1, Debadatta Mohapatra2
1Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, India.
概括
胆调节剂在治疗精神分裂症方面表现有前途,特别是改善负面症状. 虽然这些药物没有显著影响整体得分,但它们为那些对常规抗精神病药物反应有限的患者提供了新的途径.
科学领域:
- 神经科学和精神病学 在
- 药理学 药理学是指药理学的学科.
背景情况:
- 精神分裂症的治疗受到三分之一的患者抗精神病药物耐药性的挑战.
- 新兴疗法侧重于胆固醇功能障碍,准肌肉和尼古丁受体.
研究的目的:
- 评估胆固醇调节剂在精神分裂症治疗中的有效性和安全性.
- 综合新型抗精神病药物策略随机对照试验的证据.
主要方法:
- 30个随机对照试验 (3128名参与者) 的系统综述和元分析.
- 从主要数据库 (MEDLINE/PubMed,Embase,Scopus,Cochrane) 中提取的数据.
- 接下来是PRISMA指导方针,并进行了偏差风险和灵敏度分析.
主要成果:
- 胆固醇调节剂并没有显著改善整体阳性和阴性综合征量表 (PANSS) 评分.
- 在负面症状 (SMD: -0.42) 中观察到显著改善,具有中等确定性证据.
- 肌肉激动剂在PANSS领域和严重程度上表现出广泛的疗效,而尼古丁激动剂有助于消极症状.
结论:
- 胆固醇调节剂,特别是肌肉激动剂,有效地改善精神分裂症的负面症状.
- 与安慰剂相比,这些药物提供了潜在的益处,但没有显著增加副作用.
- 证据质量中等,突出了在这个领域需要进一步研究的需要.
相关概念视频
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
551
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
551
Cholinergic Antagonists: Pharmacokinetics
373
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
373
Cholinergic Antagonists: Pharmacological Actions
725
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
725
Direct-Acting Cholinergic Agonists: Pharmacokinetics
976
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
976
Direct-Acting Cholinergic Agonists: Therapeutic Uses
607
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
607
Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.1K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.1K


